Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP
about
Emodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIPInteraction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Seizure prognosis in brain tumors: new insights and evidence-based managementHistone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.The TRAIL of oncogenes to apoptosis.Cohesin is required for activation of MYC by estradiol.c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors.MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy.Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation.Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma.Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.TRAIL on trial: preclinical advances in cancer therapyModulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosisPredicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide.Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways.Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.Targeting of histone deacetylases in brain tumors.Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer.Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis.Protein kinase D2 silencing reduced motility of doxorubicin-resistant MCF7 cells.PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer.Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling.Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities.Cell death-based treatment of glioblastoma.Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
P2860
Q28581865-E272B716-912C-4988-9F1B-CC581407C4D7Q33614335-A6BE3CE0-089D-44C6-8F92-CCD3929AEF03Q33829789-D9555C4D-A192-451E-A67F-CA39131E4DE3Q33983255-F4831116-D239-4A52-8F4F-630EBA695590Q34354511-4D5899C8-60FC-4DF7-B0EB-ACD5D7A0ACAAQ34474156-F027EEC8-55D3-46C6-A1E1-355CA90BC58CQ34667550-501E59E6-136A-45FD-86F0-36121397CA77Q35036059-C8BD938D-D6E1-471B-9B79-36FE31E8A7E0Q35108007-7A6A24DD-8E77-4172-99C1-84AC64D0A64EQ36347307-8EB8E401-1511-4297-ABD8-E5FE492B36A5Q36936884-D7155CC1-A6F5-4647-A187-517D05969B60Q37049935-817593CB-5676-4822-A4B5-FF20807ED498Q37433463-FE7FC6DA-A3C7-44F1-941C-F99CB1723F2DQ37610475-6631F251-AEE9-4315-B8AD-23A12ABD63AEQ37641600-8049F9B1-AD23-4536-B1FE-43E62EF0F344Q37680195-5BF5C8A9-2BB8-4947-A5DC-06342079E567Q37716414-D83D279C-C335-464C-A511-C048D61C671DQ38233117-B74B2F2B-F462-4955-9B64-21CD72B84947Q38797635-C99F313E-02D3-4293-A6E7-99E461AAC501Q38886482-84932DAA-F008-43C2-B1E6-C668C4D2D8D7Q38887145-73D550E8-82E4-48B7-9D9B-331CF8A609C2Q38926314-2E61BF23-4564-424B-90A1-CCAB4624B453Q38947405-B3551950-A0E4-4254-8C7E-91F5F66A804EQ39047967-7F4B3D2E-40F7-459B-8E0C-E9709570139AQ45491251-722A42F4-7FFE-4F64-906A-6AB134D86205Q46237281-3D066D32-3ACF-451C-83D4-C6609C326FA0Q48163001-B8D644AA-95C3-4918-A99F-C1E2C0BE7BB2Q51206705-FFE3FEE1-D444-4675-B024-87D7844CD8EF
P2860
Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@ast
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@en
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@en-gb
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@nl
type
label
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@ast
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@en
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@en-gb
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@nl
prefLabel
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@ast
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@en
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@en-gb
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@nl
P2093
P2860
P921
P356
P1433
P1476
Histone deacetylase inhibitors ...... diated downregulation of cFLIP
@en
P2093
B A Abhari
I Eckhardt
S Cristofanon
S H K Vellanki
S Kolodziej
P2860
P2888
P304
P356
10.1038/ONC.2011.614
P407
P577
2012-01-23T00:00:00Z
P5875
P6179
1039623058